Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James R. Rusche currently holds 95,816 shares of REPLIGEN CORP (RGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Rusche has been a net seller of RGEN stock. They have purchased $89.5K and sold $2.5M worth of shares.
James R. Rusche's most recent insider trade was on Dec 23, 2016, when they sold 4,700 shares at $0.00 per share.
James R. Rusche serves as Executive at REPLIGEN CORP (RGEN). They have executed 50 insider transactions totaling $2.6M over their tenure at the company.
James R. Rusche holds the position of Executive at REPLIGEN CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
James R. Rusche has shown a selling trading pattern, with $89.5K in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James R. Rusche was on May 15, 2015, when they sold $619.8K worth of RGEN shares. This transaction involved 15,000 shares at $41.32 per share.
James R. Rusche currently owns 95,816 shares of REPLIGEN CORP (RGEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James R. Rusche's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James R. Rusche has 50 Form 4 filings on record as an insider at REPLIGEN CORP.
Set alerts for James R. Rusche and 40,000+ other insiders.